An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy
Author:
Affiliation:
1. Tel Aviv Sourasky Medical Centre; Tel Aviv Israel
2. Queen's Hospital; Burton upon Trent UK
3. The Royal Marsden NHS Foundation Trust; London UK
4. Division of Molecular Pathology; The Institute of Cancer Research; London UK
Funder
Arbib Foundation
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13767/fullpdf
Reference9 articles.
1. Comparative Histological Study on the Spleen of Human (Homo sapiens), Cow (Bos indicus) and Goat (Capra hircus);Alim;Nepal Journal of Medical Sciences,2012
2. Leukemic reticuloendotheliosis;Bouroncle;Blood,1958
3. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience;Chadha;Blood,2005
4. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis;Else;British Journal of Haematology,2009
5. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence;Else;Leukemia & Lymphoma,2011
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues;Blood Reviews;2022-01
2. Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia;New England Journal of Medicine;2021-05-13
3. Treatment of hairy cell leukemia;Expert Review of Hematology;2020-09-24
4. Development of Recombinant Immunotoxins for Hairy Cell Leukemia;Biomolecules;2020-08-03
5. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia;Journal of Clinical Oncology;2020-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3